Gilead (Nasdaq: GILD) is close to an agreement to acquire Delaware-based biopharmaceutical company Incyte (Nasdaq: INCY), according to a person ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE